7 research outputs found

    Simple tool in a complex case:use of the nailfold capillaroscopy

    Get PDF
    summary:Let Bw(p)B_w(\ell ^p) denote the space of infinite matrices AA for which A(x)pA(x)\in \ell ^p for all x={xk}k=1px=\{x_k\}_{k=1}^\infty \in \ell ^p with xk0|x_k|\searrow 0. We characterize the upper triangular positive matrices from Bw(p)B_w(\ell ^p), 1<p<1<p<\infty , by using a special kind of Schur multipliers and the G. Bennett factorization technique. Also some related results are stated and discussed

    Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    No full text

    Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    No full text
    IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18, REL, CD28, PF4V1, LY86, LYN, ANXA3, TNFSF8/TNFSF15, REEP3, ZMIZ1, OVOL1/RELA, ETS1, IGH, IRF8, TNFRSF13B and FCAR. The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand-receptor pairs, prioritizing potential new drug targets

    Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    No full text
    : IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18, REL, CD28, PF4V1, LY86, LYN, ANXA3, TNFSF8/TNFSF15, REEP3, ZMIZ1, OVOL1/RELA, ETS1, IGH, IRF8, TNFRSF13B and FCAR. The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand-receptor pairs, prioritizing potential new drug targets
    corecore